Nantes University Hospital
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Private
- Established
- 1503-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- https://www.chu-nantes.fr
A Multi-center Open-label Phase 2 Study of Ixazomib, Iberdomide and Dexamethasone in Elderly Patients With Multiple Myeloma at First Relapse."
Phase 2
Active, not recruiting
- Conditions
- Multiple Myeloma at First Relapse
- Interventions
- First Posted Date
- 2021-08-10
- Last Posted Date
- 2025-04-06
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 75
- Registration Number
- NCT04998786
- Locations
- 🇫🇷
CH de la cote basque, Bayonne, France
🇫🇷CHRU Hopital Haut Lévêque, Bordeaux, France
🇫🇷CHU, Toulouse, France
Quantifying Gait Alteration in Multiple Sclerosis Using a Wearable Device
Completed
- Conditions
- Multiple Sclerosis
- Interventions
- Other: Wearable sensor
- First Posted Date
- 2021-07-21
- Last Posted Date
- 2022-06-03
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 44
- Registration Number
- NCT04969848
- Locations
- 🇫🇷
Nantes University Hospital, Nantes, Loire-Atlantique, France
Orthodontic Retention In France - ORIF
Completed
- Conditions
- Orthodontic Retention Procedures
- First Posted Date
- 2021-07-08
- Last Posted Date
- 2021-07-08
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 262
- Registration Number
- NCT04954976
- Locations
- 🇫🇷
Nantes University Hospital, Nantes, Loire-Atlantique, France
Follow-up During the Peripubertal Period of Preterm Children Included in the Protocol Entitled "EPIPOD".
Not Applicable
Recruiting
- Conditions
- Preterm Children
- Interventions
- Other: clinical and biological measurements and questionnaires
- First Posted Date
- 2021-06-30
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 114
- Registration Number
- NCT04945369
- Locations
- 🇫🇷
Nantes University Hospital, Nantes, France
" SAVE Study (Switch AdVagraf® to Envarsus®) for Fast Metabolizers Kidney Transplant Recipients"
Recruiting
- Conditions
- Renal Transplant Failure
- Interventions
- Other: No intervention
- First Posted Date
- 2021-06-30
- Last Posted Date
- 2023-08-04
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 225
- Registration Number
- NCT04945785
- Locations
- 🇫🇷
CHU de Nantes, Nantes, France
Impact of Antimicrobial Stewardship on Outcomes of Patients With Hospital-acquired Pneumonia Due to Gram-negative Bacilli - A Before-after Study
Completed
- Conditions
- Hospital-acquired Pneumonia
- Interventions
- Other: No intervention
- First Posted Date
- 2021-06-23
- Last Posted Date
- 2022-02-17
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 420
- Registration Number
- NCT04937075
- Locations
- 🇫🇷
CHU de Nantes, Nantes, France
🇫🇷CHU Rennes, Rennes, France
INS, B Cells and Microbiota
Recruiting
- Conditions
- MicrobiotaT-lymphocytesB-lymphocytesGlomerulosclerosis
- Interventions
- Other: Measurement of blood immune populations and microbiota distribution.
- First Posted Date
- 2021-06-14
- Last Posted Date
- 2024-07-30
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT04924712
- Locations
- 🇫🇷
Nantes University Hospital, Nantes, Loire-Atlantique, France
🇫🇷Departemental Hospital Center, La Roche-sur-Yon, France
Correlation of Aortic Versus Pulmonary ITV in Response to Vascular Filling
Completed
- Conditions
- Sepsis With Hemodynamic Instability
- First Posted Date
- 2021-05-24
- Last Posted Date
- 2023-06-13
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 26
- Registration Number
- NCT04899323
- Locations
- 🇫🇷
Nantes University Hospital, Nantes, Loire-Atlantique, France
Real-life Data of Constitutional Von Willebrand Disease in Western France
Completed
- Conditions
- Von Willebrand Diseases
- First Posted Date
- 2021-05-14
- Last Posted Date
- 2025-03-30
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 922
- Registration Number
- NCT04887324
- Locations
- 🇫🇷
CHU Angers, Angers, France
🇫🇷CHR de Brest, Brest, France
🇫🇷CHU de Nantes, Nantes, France
Injection of Lymphocytes From Haplo-identical Donor Following Chemotherapy in Patients With High-risk Acute Myeloblastic Leukemia Not Eligible for an Allogeneic Hematopoietic Stem Cell Transplantation
Phase 1
Recruiting
- Conditions
- Acute Myeloid Leukemia (AML)
- First Posted Date
- 2021-05-13
- Last Posted Date
- 2022-05-11
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 12
- Registration Number
- NCT04886206
- Locations
- 🇫🇷
CHU de Nantes, Nantes, France
© Copyright 2025. All Rights Reserved by MedPath